Association between erythrocyte Na+K+-ATPase activity and some blood lipids in type 1 diabetic patients from Lagos, Nigeria

BMC Endocrine Disorders

Volumn 7, Issue , 2007, Pages

  Iwalokun, Bamidele A ^a   Iwalokun, Senapon O ^a  

^a LAGOS STATE UNIVERSITY   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DIGOXIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME KINETICS; ERYTHROCYTE MEMBRANE; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NIGERIA; PROTEIN CONTENT; SPECTROPHOTOMETRY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 35648987115     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-7-7     Document Type: Article

References (49)

1. World Health Organization Diabetes Mellitus: Report of a WHO study group Technical Report Series Geneva WHO 1985:727
2. Carneiro AV Coronary heart disease in diabetes mellitus: Risk factors and epidemiology Rev Port Cardiol 2004, 23:1359-1366 15641298
3. Budak Y Demirci H Akdogan M Yavuz D Erythrocyte membrane anionic charge in type 2 diabetic patients with retinopathy BMC Ophthalmology 2004, 4:14-19 526283 15473902 10.1186/1471-2415-4-14
4. Naka K Sasaki H Kishi Y Furuta M Sanke T Nanjo K Mukoyama M Effects of cilostazol on development of experimental diabetic neuropathy: functional and structural studies, and Na+ -K+ -ATPase acidity in peripheral nerve in rats with streptozotocin-induced diabetes Diabetes Res Clin Pract 1995, 30:153-162 10.1016/0168-8227(95)01184-6 8861454
5. Kaplan JH Biochemistry of Na, K-ATPase Annu Rev Biochem 2002, 71:511-535 10.1146/annurev.biochem.71.102201.141218 12045105
6. Vague P Dufayet D Coste T Moriscot C Jannot MF Raccah D Association of diabetic neuropathy with Na/K ATPase gene polymorphism Diabetologia 1997, 40:506-511 10.1007/s001250050708 9165217
7. Lambourne JE Brown AM Calcutt N Tomlinson DR Willars GB Adenosine triphosphatase in nerves and ganglia of rats with streptozotocin-induced diabetes or galactosaemia; effects of aldose reductase inhibition Diabetologia 1988, 31:379-384 10.1007/BF02341507 2970984
8. Djemli-Shipkolye A Coste T Raccah D Vague P Pieroni G Gerbi A Na, K-ATPase alterations in diabetic rats: Relationship with lipid metabolism and nerve physiological parameters Cell Mol Biol (Noisy-le-grand) 2001, 47:297-304 11355004
9. Soulis-Liparota T Cooper ME Dunlop M Jerums G The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat Diabetologia 1995, 38:1492-1493 10.1007/BF00400619 8786032
10. Di Leo MA Santini SA Cercone S Lepore D Gentiloni Silveri N Caputo S Greco AV Giardina B Franconi F Ghirlanda G Chronic taurine supplementation ameliorates oxidative stress and Na+ K+ ATPase impairment in the retina of diabetic rats Amino Acids 2002, 23:401-406 10.1007/s00726-002-0202-2 12436207
11. Kowluru RA Retinal metabolic abnormalities in diabetic mouse: Comparison with diabetic rat Curr Eye Res 2002, 24:123-128 10.1076/ ceyr.24.2.123.8158 12187484
12. Kato N Mizuno K Makino M Suzuki T Yagihashi S Effects of 15-month aldose reductase inhibition with fidarestat on the experimental diabetic neuropathy in rats Diabetes Res Clin Pract 2000, 50:77-85 10.1016/ S0168-8227(00)00164-9 10960717
13. Rabini RA Petruzzi E Staffolani R Tesei M Fumelli P Pazzagli M Mazzanti L Diabetes mellitus and subjects' ageing: A study on the ATP content and ATP-related enzyme activities in human erythrocytes Eur J Clin Invest 1997, 27:327-332 10.1046/j.1365-2362.1997.1130652.x 9134382
14. Mazzanti L Rabini RA Salvolini E Tesei M Martarelli D Venerando B Curatola G Sialic acid, diabetes, and aging: A study on the erythrocyte membrane Metabolism 1997, 46:59-61 10.1016/S0026-0495(97)90168-2 9005970
15. De La Tour DD Raccah D Jannot MF Coste T Rougerie C Vague P Erythrocyte Na/K ATPase activity and diabetes: Relationship with C-peptide level Diabetologia 1998, 41:1080-1084 10.1007/s001250051033 9754827
16. Adewoye OE Bolarinwa AF Olorunsogo OO Ca++, Mg++-ATPase activity in insulin-dependent and non-insulin dependent diabetic Nigerians Afr J Med Med Sci 2000, 29:195-199 11713988
17. Adewoye EO Akinlade KS Olorunsogo OO Erythrocytemembrane protein alteration in diabetics East Afr Med J 2001, 78:438-440 11921569
18. Okegbile EO Odusan O Adeola O Erythrocyte membrane digoxin-sensitive (Na(+)-K+)-ATPase of non-insulin dependent diabetic humans Biosci Rep 1997, 17:499-506 10.1023/A:1027352005421 9419391
19. DeLuise M Blackburn GL flier JS Reduced activity of the red cell sodium-potassium pump in human obesity N Engl J Med 1980, 303:1017-1022 6252462
20. Perusicova J Prevalence of dyslipidaemia, hypertension and vascular complications in newly manifested diabetics (Prospective study: Part 2) Vnitr Lek 2001, 47:146-150 15635875
21. Iwalokun BA Ogunfemi MK gbajabiamila B Olukosi YA Incidence and evaluation of the risk factors of microalbuminuria among diabetics and non-diabetics in Lagos. Nigeria Niger J Health Biomed Sci 2006, 5:81-88
22. Rabini RA Galassi R Fumelli P Dousset N Solera ML Valdiguie P Curatola G Ferretti G Taus M Mazzanti L Reduced Na(+)-K(+)-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients Diabetes 1994, 43:915-919 10.2337/diabetes.43.7.915 8013757
23. Kiziltunc A Aklay F Polat F Kuskay S Sahin YN Reduced lecithin:cHolesterol acyl transferase (LACAT) and Na+K+-ATpase activity in diabetic patients Clin Biochem 1997, 30:177-182 10.1016/ S0009-9120(96)00156-7 9127701
24. Jarikre AE Oluwatowoju IO Emuveyan EE Fasting blood glucose and lipid profiles studies in adult on-set obesity of short duration in the Lagos Area of Nigeria Niger Med J 2000, 38:18-19
25. Krahulec B Vozar J Incidence of risk factors and vascular complications in patients with newly diagnosed type 2 diabetes mellitus Vnitr Lek 2002, 48:1031-1038 12577454
26. Siedel J Hagele EO Ziegenborn J Wahlefield AW Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficacy Clin Chem 1983, 29:1075-1080 6851096
27. McGowan MW Attiss JD Strandbergh DR Zak BA Peroxide-coupled method for the colorimetric determination of serum triglycerides Clin Chem 1983, 29:538-542 6825269
28. Lopez-Virrela M Stone P Ellis S Colwell JA Cholesterol determination in high density lipoproteins separated by three different methods Clin Chem 1977, 28:882-883
29. Friedewald WT Levy RI Fredrickson DS Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge Clin Chem 1972, 18:499-502 4337382
30. Recognition and management of hyperlipidaemia in adults. A policy statements of the European Artherosclerosis Society Eur-Heart J 1988, 9:571-600 3402474
31. Issel Bacher KJ Brawnwald E Wilson JD Martin JB Fauci AS Kasper DL Eds Appendix-Laboratory values of clinical importance In: Harrison's principle of internal Medicine 13th International Education McGraw Hill Inc 1994:2489-2496
32. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 2002, 106:3143-3421 12485966
33. DeLuise M Flier JS Functionally abnormal Na+K+-ATPase pump in erythrocytes of a morbidly obese patient J Clin Invest 1982, 69:38-44 371166 6274916
34. Fiske CH Subbarrow Y The colorimetric determination of phosphorous J Biol Chem 1925, 66:375-400
35. Lowry OH Rosebrough NJ Farr AL Randall RJ Protein measurement with Folin phenol reagent J Biol Chem 1951, 193:265-275 14907713
36. Kunt T Schneider S Pfutzner A Goitum K Engelbach M Schauf B Beyer J Forst T The effect of human proinsulin C-peptide on erythrocyte deformability in patients with Type I diabetes mellitus Diabetologia 1999, 42:465-471 10.1007/s001250051180 10230651
37. Forst T Kunt T Effects of C-peptide on microvascular blood flow and blood hemorheology Exp Diabesity Res 2004, 5:51-64 10.1080/ 15438600490424532 15198371
38. Mimura M Makino H Kanatsuka A Asai T Yoshida S Reduction of erythrocyte (Na(+)-K+)ATPase activity in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria Horm Metab Res 1994, 26:33-38 8150421
39. Mimura M Makino H Kanatsuka A Yoshida S Reduction of erythrocyte (Na(+)-K+) ATPase activities in non-insulin-dependent diabetic patients with hyperkalemia Metabolism 1992, 41:426-430 10.1016/ 0026-0495(92)90079-P 1313528
40. Agaba EI Agaba PA Puepet FH Prevalence of microalbuminuria in newly diagnosed type 2 diabetic patients in Jos Nigeria AfrJ Med Med Sci 2004, 33:19-22
41. Nandhini TA Anuradha CV Inhibition of lipid peroxidation, protein glycation and elevation of membrane ion pump activity by taurine in RBC exposed to high glucose Clin Chim Acta 2003, 336:129-135 10.1016/ S0009-8981(03)00337-1 14500045
42. Gonzalez Flecha FL Bermudez MC Cedola NV Gagliardino JJ Rossi JP Decreased Ca2(+)-ATPase activity after glycosylation of erythrocyte membranes in vivo and in vitro Diabetes 1990, 39:707-711 10.2337/ diabetes.39.6.707 2140803
43. Yagihashi S Yamagishi S Wada R Perspective for the treatment of diabetic neuropathy: Translation from molecular studies to bedside Rinsho Shikeigaku 2005, 45:966-968
44. Sampathkumar R Balasubramanyam M Tara C Rema M Mohan V Association of hypogluthathionemia with reduced Na+K+-ATPase activity in type 2 diabetic microangiopathy Mol Cell Biochem 2006, 202:169-176 10.1007/ s11010-006-1740-9
45. Balogun SO Monitoring of Diabetic Control. A paper presented at the Scientific conference of the Nigerian Society of Endocrinology and Metabolism Conference Centre University of Lagos, Nigeria 6-7 2000, August 2-5
46. Baldini P Incerpi S Lambert-Gardini S Spinedi A Luly P Membrane lipid alterations and Na+-pumping activity in erythrocytes from IDDM and NIDDM subjects Diabetes 1989, 38:825-831 10.2337/diabetes.38.7.825 2544470
47. Erciyas F Taneli F Arslan B Uslu Y Glycemic control, oxidative stress, and lipid profile in children with type 1 diabetes mellitus Arch med Res 2004, 35:134-140 10.1016/j.arcmed.2003.10.002 15010193
48. Wiley JS Ellory JC Shuman MA Shaller CC Copper RA Characteristics of membrane defect in the hereditary stomatocytosis syndrome Blood 1975, 46:337-356 1148392
49. Hotta N Kakuta H Fukasawa H Kimura M Koh N Matsumae H Fujimaki M Sakamoto N Efficacy of glucose, ouabain and an aldose reductase inhibitor on 2-[3H] myo-inositol uptake by human, rat and rabbit erythrocytes Horm Metab Res 1988, 20:387-390 3139540